Key Findings
- Self-rated sexual desire increased significantly at 8 and 12 weeks vs placebo (p < 0.01)
- Testosterone and estradiol levels were not affected, suggesting a non-hormonal mechanism
- Both 1,500mg and 3,000mg doses improved libido, with no clear dose-response advantage
- No significant adverse effects were reported at either dose
- Mood and energy scores showed trends toward improvement but did not reach significance